Gordon Mills

Professor

  • 100179 Citations
  • 146 h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Gordon Mills is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 43 Similar Profiles
Neoplasms Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Phosphatidylinositol 3-Kinase Medicine & Life Sciences
Mutation Medicine & Life Sciences
Tumors Chemical Compounds
Phosphorylation Medicine & Life Sciences
Cell Line Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1996 2016

Research Output 1976 2019

Author Correction: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis (Nature Communications, (2018), 9, 1, (5426), 10.1038/s41467-018-07126-9)

Liu, S., Zhang, G., Guo, J., Chen, X., Lei, J., Ze, K., Dong, L., Dai, X., Gao, Y., Song, D., Ecker, B. L., Yang, R., Feltcher, C., Peng, K., Feng, C., Chen, H., Lee, R. X., Kerestes, H., Niu, J., Kumar, S. & 15 others, Xu, W., Zhang, J., Wei, Z., Martin, J. S., Liu, X., Mills, G., Lu, Y., Guo, W., Sun, L., Zhang, L., Weeraratna, A., Herlyn, M., Wei, W., Lee, F. S. & Xu, X., Dec 1 2019, In : Nature communications. 10, 1, 1211.

Research output: Contribution to journalComment/debate

Open Access
document markup languages
HTML
communication
Communication

Breast cancer quantitative proteome and proteogenomic landscape

Consortia Oslo Breast Cancer Research Consortium (OSBREAC), Dec 1 2019, In : Nature communications. 10, 1, 1600.

Research output: Contribution to journalArticle

Open Access
proteome
Proteome
breast
Tumors
tumors
1 Citation (Scopus)

Combined MEK and Bcl-2/X L inhibition is effective in high-grade serous ovarian cancer patient–derived xenograft models and BIM levels are predictive of responsiveness

Iavarone, C., Zervantonakis, I. K., Selfors, L. M., Palakurthi, S., Liu, J. F., Drapkin, R., Matulonis, U. A., Hallberg, D., Velculescu, V. E., Leverson, J. D., Sampath, D., Mills, G. & Brugge, J. S., Mar 1 2019, In : Molecular cancer therapeutics. 18, 3, p. 642-655 14 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
Heterografts
Ovarian Neoplasms
MAP Kinase Signaling System
Drug Combinations

Confocal fluorescence microscopy platform suitable for rapid evaluation of small fragments of tissue in surgical pathology practice

Krishnamurthy, S., Ban, K., Shaw, K., Mills, G., Sheth, R., Tam, A., Gupta, S. & Sabir, S., Mar 1 2019, In : Archives of Pathology and Laboratory Medicine. 143, 3, p. 305-313 9 p.

Research output: Contribution to journalArticle

Open Access
Surgical Pathology
Fluorescence Microscopy
Confocal Microscopy
Hematoxylin
Eosine Yellowish-(YS)

Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

Liu, S., Li, S., Wang, B., Liu, W., Gagea, M., Chen, H., Sohn, J., Parinyanitikul, N., Primeau, T., Do, K. A., Vande Woude, G. F., Mendelsohn, J., Ueno, N. T., Mills, G., Tripathy, D. & Gonzalez-Angulo, A. M., Feb 1 2019, In : Molecular cancer therapeutics. 18, 2, p. 399-412 14 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Phosphatidylinositol 3-Kinases
Heterografts
Proteomics
Therapeutics